Eplerenone for chronic central serous chorioretinopathy in patients with active, previously untreated disease for more than 4 months (VICI): a randomised, double-blind, placebo-controlled trial

Autor: Lotery, Andrew, Sivaprasad, Sobha, O'Connell, Abby, Harris, Rosie A, Culliford, Lucy, Ellis, Lucy, Cree, Angela, Madhusudhan, Savita, Behar-Cohen, Francine, Chakravarthy, Usha, Peto, Tunde, Rogers, Chris A, Reeves, Barnaby C, Bellani, Samir, Griffiths, Helen, Thulasidharan, Suresh, Watkins, Catrin, Kaye, Rebecca, Menon, Deepthy, Neville, Qin, Denham, Rebecca, Gillvray, Karen, Abugreen, Salwa, Nixon, Natalie, Alarbi, Mohammed, Ghanchi, Faruque, Madanat, Zeid, Hawes, Nicola, Hughes, Edward, Keir, Campbell, Kisza, Krystian, Bailey, Clare, Hazlewood, Phillippa, Cloake, Julie, Menon, Geeta, Chandran, Manju, Raguro, Abigail, Mohamed, Moin, Lim, Wei Sing, Eleftheriadis, Haralabos, Efraimidis, Stefanos, McKibbin, Martin, Mukherjee, Raj, Wilson, Joanne, Lenfestey, Pauline, Harding, Simon, Haigh, Kelly, Chhabra, Ramandeep, Horani, Mania, Platt, Raisa-Marie, Talks, James, Bhatia, Devanga, Andrews, Violet, Downes, Susan, Samuel, Ivy, Buttress, Daniel, Pagliarini, Sergio, Randle, Linzi, Allison, Jeanette, Brand, Christopher, Edwards, Maria, Karia, Niral, Shipman, Maria, Thompson, Elridge, Kotagiri, Ajay, Steel, David, Dodds, Steven, Turner, Stephen, Osoba, Yinka, Criddle, Sharon, Yang, Yit, Narendran, Niro, Karpoor, Meena, Gale, Richard, Airody, Archana, Grice-Holt, Alison

Publikováno v: The Lancet; January 2020, Vol. 395 Issue: 10220 p294-303, 10p